Gossamer Bio Inc reports results for the quarter ended in June - Earnings Summary

Gossamer Bio

13/08/2024 02:14

* Gossamer Bio Inc  GOSS.OQ  reported quarterly adjusted
earnings
of 22 cents​​ per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of -45 cents.  The mean expectation of ten analysts for the
quarter was for earnings of 23 cents per share. Wall Street
expected results to range from -20 cents to 55 cents per share.
    * Revenue was $95.84 million​; analysts expected $114.29
million. 
    * Gossamer Bio Inc's reported EPS for the quarter was 22
cents​.
    * The company reported quarterly net income of $49.23
million.
    * Gossamer Bio Inc shares had fallen by 12.2% this
quarter and
lost 13.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 31.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Gossamer Bio Inc
is $7.00 
This summary was machine generated from LSEG data August 13 at
01:13 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.23           0.22           Missed
 Mar. 31 2024      -0.19          -0.19          Met
 Dec. 31 2023      -0.21          -0.21          Met
 Sep. 30 2023      -0.26          -0.21          Beat